The FDA approved UPTRAVI® (selexipag) injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adult patients with WHO functional class (FC) II–III, who are temporarily unable to take oral therapy
In preparation for launch, Resverlogix will utilize EVERSANA’s fully integrated commercialization services
Evio will work to improve medication affordability and patients’ clinical outcomes and medication experiences. The five plans in total provide coverage to more than 20 million members across the United States.
Biologics specialty pharmacy teams includes pharmacists with in-depth knowledge of therapies, experienced nurses, and financial counselors who are familiar with various financial assistance programs and organizations that help patients
Accredo is the only specialty pharmacy (SP) that prepares and ships Evrysdi directly to patients each month. Evrysdi is not available at retail pharmacies
The combined entity, to be named Datavant, will be the nation’s largest health data ecosystem
The FDA approved Paratek’s supplemental New Drug Application (sNDA) for the oral-only dosing regimen of NUZYRA® for the treatment of adults with Community-Acquired Bacterial Pneumonia (CABP)
McKesson recently announced that RelayHealth, McKesson Prescription Automation, CoverMyMeds, and RxCrossroads by McKesson, are coming together as one brand under the CoverMyMeds umbrella.